[1]
Salimah, K., Hardianti, M.S., Anggorowati, N. and Taroeno-Hariadi, K. 2026. Co-expression of BCL2 and C-MYC as a Potential Predictive Factor of Survival in Diffuse Large B Cell Lymphoma with Rituximab-Based Chemotherapy. Asian Pacific Journal of Cancer Biology. 11, 1 (Jan. 2026), 23-29. DOI:https://doi.org/10.31557/apjcb.2026.11.1.23-29.